Beta-2 microglobulin is an amyloidogenic protein in man. 1985

P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione

Curvilinear fibrils with the tinctorial properties of amyloid were isolated from a patient with bone and joint involvement complicating chronic dialysis for renal disease. Subunit fractions of 24,000 and 12,000 mol wt were identified after gel filtration under dissociating conditions, the latter containing a significant amount of a dimer of the former. This was confirmed by Edman degradation of each fraction, which yielded the amino terminal sequence of normal human beta-2 microglobulin (B2M) to residues 20 and 30, respectively. The size of the subunit protein (12,000 mol wt) and the amino acid composition make it likely that intact B2M is a major constituent of the fibrils. B2M is thus another example of a low molecular weight serum protein, with a prominent beta-pleated sheet structure, that may adopt the fibrillar configuration of amyloid in certain pathologic states.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin

Related Publications

P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
August 2001, The Journal of biological chemistry,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
October 1996, Kidney international,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
June 1987, Journal of immunology (Baltimore, Md. : 1950),
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
January 1988, Blood purification,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
January 1981, Scandinavian journal of immunology,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
March 2001, Journal of molecular biology,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
March 2002, The Journal of biological chemistry,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
November 1982, The New England journal of medicine,
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
November 1989, Science (New York, N.Y.),
P D Gorevic, and T T Casey, and W J Stone, and C R DiRaimondo, and F C Prelli, and B Frangione
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!